LSV Asset Management’s Emergent Biosolutions EBS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.2M Sell
815,591
-15,600
-2% -$99.5K 0.01% 465
2025
Q1
$4.04M Buy
831,191
+809,591
+3,748% +$3.94M 0.01% 500
2024
Q4
$206K Buy
+21,600
New +$206K ﹤0.01% 749
2023
Q3
Sell
-40,700
Closed -$299K 867
2023
Q2
$299K Sell
40,700
-30,576
-43% -$225K ﹤0.01% 796
2023
Q1
$738K Sell
71,276
-34,400
-33% -$356K ﹤0.01% 689
2022
Q4
$1.25M Hold
105,676
﹤0.01% 635
2022
Q3
$2.22M Hold
105,676
0.01% 586
2022
Q2
$3.28M Hold
105,676
0.01% 561
2022
Q1
$4.34M Buy
105,676
+14,200
+16% +$583K 0.01% 545
2021
Q4
$3.98M Buy
91,476
+61,176
+202% +$2.66M 0.01% 570
2021
Q3
$1.52M Hold
30,300
﹤0.01% 670
2021
Q2
$1.91M Hold
30,300
﹤0.01% 651
2021
Q1
$2.82M Sell
30,300
-2,700
-8% -$251K ﹤0.01% 635
2020
Q4
$2.96M Buy
33,000
+7,100
+27% +$636K 0.01% 636
2020
Q3
$2.68M Hold
25,900
0.01% 624
2020
Q2
$2.05M Sell
25,900
-4,600
-15% -$364K ﹤0.01% 666
2020
Q1
$1.76M Buy
+30,500
New +$1.76M ﹤0.01% 659
2018
Q4
Sell
-17,700
Closed -$1.17M 977
2018
Q3
$1.17M Sell
17,700
-53,700
-75% -$3.53M ﹤0.01% 794
2018
Q2
$3.6M Sell
71,400
-144,200
-67% -$7.28M 0.01% 661
2018
Q1
$11.4M Sell
215,600
-530,918
-71% -$28M 0.02% 463
2017
Q4
$34.7M Buy
746,518
+90,971
+14% +$4.23M 0.05% 291
2017
Q3
$26.5M Buy
655,547
+20,832
+3% +$843K 0.04% 318
2017
Q2
$21.5M Buy
634,715
+12,000
+2% +$407K 0.04% 348
2017
Q1
$18.1M Buy
622,715
+78,500
+14% +$2.28M 0.03% 364
2016
Q4
$17.9M Buy
544,215
+159,680
+42% +$5.24M 0.03% 369
2016
Q3
$12.1M Buy
384,535
+82,500
+27% +$2.6M 0.02% 405
2016
Q2
$8.49M Buy
302,035
+90,038
+42% +$2.53M 0.02% 450
2016
Q1
$7.71M Sell
211,997
-98,500
-32% -$3.58M 0.02% 449
2015
Q4
$12.4M Buy
310,497
+125,017
+67% +$5M 0.03% 349
2015
Q3
$5.28M Buy
185,480
+6,878
+4% +$196K 0.01% 479
2015
Q2
$5.88M Buy
178,602
+60,936
+52% +$2.01M 0.01% 464
2015
Q1
$3.38M Sell
117,666
-95,409
-45% -$2.74M 0.01% 539
2014
Q4
$5.8M Buy
213,075
+208,175
+4,248% +$5.67M 0.01% 444
2014
Q3
$104K Hold
4,900
﹤0.01% 849
2014
Q2
$110K Buy
+4,900
New +$110K ﹤0.01% 821